BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 21998035)

  • 1. Dissecting the Self-assembly Dynamics of Imperfect Repeats in α-Synuclein.
    Huang F; Wang Y; Zhang Y; Wang C; Lian J; Ding F; Sun Y
    J Chem Inf Model; 2023 Jun; 63(11):3591-3600. PubMed ID: 37253119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-Toxicity Relationship in Intermediate Fibrils from α-Synuclein Condensates.
    Chen SW; Barritt JD; Cascella R; Bigi A; Cecchi C; Banchelli M; Gallo A; Jarvis JA; Chiti F; Dobson CM; Fusco G; De Simone A
    J Am Chem Soc; 2024 Apr; 146(15):10537-10549. PubMed ID: 38567991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coupling of the non-amyloid-component (NAC) domain and the KTK(E/Q)GV repeats stabilize the α-synuclein fibrils.
    Xu L; Nussinov R; Ma B
    Eur J Med Chem; 2016 Oct; 121():841-850. PubMed ID: 26873872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Glutamate Arginylation on α-Synuclein: Studying an Unusual Post-Translational Modification through Semisynthesis.
    Pan B; Kamo N; Shimogawa M; Huang Y; Kashina A; Rhoades E; Petersson EJ
    J Am Chem Soc; 2020 Dec; 142(52):21786-21798. PubMed ID: 33337869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of KTKEGV repeat motif and intervening ATVA sequence on α-synuclein solubility and assembly.
    Brontesi L; Imberdis T; Ramalingam N; Dettmer U
    J Neurochem; 2023 Apr; 165(2):246-258. PubMed ID: 36625497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cysteine-Based Mimic of Arginylation Reproduces Neuroprotective Effects of the Authentic Post-Translational Modification on α-Synuclein.
    Pan B; Shimogawa M; Zhao J; Rhoades E; Kashina A; Petersson EJ
    J Am Chem Soc; 2022 May; 144(17):7911-7918. PubMed ID: 35451816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining non-canonical amino acid mutagenesis and native chemical ligation for multiply modifying proteins: A case study of α-synuclein post-translational modifications.
    Galesic A; Pan B; Ramirez J; Rhoades E; Pratt MR; Petersson EJ
    Methods; 2023 Oct; 218():101-109. PubMed ID: 37549799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a hydroxyflavone-labelled 4554W peptide probe for monitoring αS aggregation.
    Watt KJC; Meade RM; James TD; Mason JM
    Sci Rep; 2023 Jul; 13(1):10968. PubMed ID: 37414785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α-synuclein-assisted oligomerization of β-amyloid (1-42).
    Chau E; Kim JR
    Arch Biochem Biophys; 2022 Mar; 717():109120. PubMed ID: 35041853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering of a protein probe with multiple inputs and multiple outputs for evaluation of alpha synuclein aggregation states.
    Chau E; Kim JR
    Biochem Eng J; 2022 Jan; 178():. PubMed ID: 35002469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of alpha-synuclein aggregation by AM17, a synthetic resveratrol derivative.
    Chau E; Kim H; Shin J; Martinez A; Kim JR
    Biochem Biophys Res Commun; 2021 Oct; 574():85-90. PubMed ID: 34454326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between Soluble Species of β-Amyloid and α-Synuclein Promote Oligomerization while Inhibiting Fibrillization.
    Candreva J; Chau E; Rice ME; Kim JR
    Biochemistry; 2020 Feb; 59(4):425-435. PubMed ID: 31854188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A KLVFFAE-Derived Peptide Probe for Detection of Alpha-Synuclein Fibrils.
    Wood A; Chau E; Yang Y; Kim JR
    Appl Biochem Biotechnol; 2020 Apr; 190(4):1411-1424. PubMed ID: 31776941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intramolecular distance between amyloidogenic domains on amyloid aggregation.
    Ko A; Kim JR
    Int J Mol Sci; 2012 Sep; 13(10):12169-81. PubMed ID: 23202890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creation of aggregation-defective α-synuclein variants by engineering the sequence connecting β-strand-forming domains.
    Hernandez M; Golbert S; Zhang LG; Kim JR
    Chembiochem; 2011 Nov; 12(17):2630-9. PubMed ID: 21998035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid-state NMR reveals structural differences between fibrils of wild-type and disease-related A53T mutant alpha-synuclein.
    Heise H; Celej MS; Becker S; Riedel D; Pelah A; Kumar A; Jovin TM; Baldus M
    J Mol Biol; 2008 Jul; 380(3):444-50. PubMed ID: 18539297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial Parkinson disease mutations influence α-synuclein assembly.
    Ono K; Ikeda T; Takasaki J; Yamada M
    Neurobiol Dis; 2011 Sep; 43(3):715-24. PubMed ID: 21684335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cu2+ binding modes of recombinant alpha-synuclein--insights from EPR spectroscopy.
    Drew SC; Leong SL; Pham CL; Tew DJ; Masters CL; Miles LA; Cappai R; Barnham KJ
    J Am Chem Soc; 2008 Jun; 130(24):7766-73. PubMed ID: 18494470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
    Meredith SC
    Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.